{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:40:39Z","timestamp":1776213639826,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R01MD014712-01"],"award-info":[{"award-number":["R01MD014712-01"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIDDK 1K23DK114566-01A1"],"award-info":[{"award-number":["NIDDK 1K23DK114566-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1 R03 DK129626-01"],"award-info":[{"award-number":["1 R03 DK129626-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jnma.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:12:53Z","timestamp":1652746373000},"page":"S3-S9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S2","title":["Etiopathogenesis of kidney disease in minority populations and an updated special focus on treatment in diabetes and hypertension"],"prefix":"10.1016","volume":"114","author":[{"given":"Ebele M.","family":"Umeukeje","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine T.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne B.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jnma.2022.05.004_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11886-019-1251-4","article-title":"Evidence for and against ACC\/AHA 2017 guideline for target systolic blood pressure of <\u2009130 mmHg in persons with type 2 diabetes","volume":"21","author":"Shen","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"10.1016\/j.jnma.2022.05.004_bib0002","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jnma.2022.05.004_bib0003","unstructured":"Chronic Kidney Disease in the United States. US Department of Health and Human Services, Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2021. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2021. https:\/\/www.cdc.gov\/kidneydisease\/publications-resources\/CKD-national-facts.html"},{"issue":"3s","key":"10.1016\/j.jnma.2022.05.004_bib0004","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","volume":"99","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.jnma.2022.05.004_bib0005","series-title":"Chronic Kidney Disease Surveillance System","year":"2021"},{"issue":"2","key":"10.1016\/j.jnma.2022.05.004_bib0006","first-page":"77","article-title":"Masked hypertension: lessons for the future","volume":"89","author":"Penmatsa","year":"2020","journal-title":"Ulster Med J"},{"issue":"4","key":"10.1016\/j.jnma.2022.05.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3718","article-title":"Will the 2021 USPSTF hypertension screening recommendation decrease or worsen racial\/ethnic disparities in blood pressure control?","volume":"4","author":"Ferdinand","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jnma.2022.05.004_bib0008","doi-asserted-by":"crossref","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.jnma.2022.05.004_bib0009","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MAJ.0000000000000308","article-title":"Racial differences in hypertension: implications for high blood pressure management","volume":"348","author":"Lackland","year":"2014","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.jnma.2022.05.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003166","article-title":"Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension: the national health and nutrition examination survey, 2003\u20132012","volume":"10","author":"Gu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"10.1016\/j.jnma.2022.05.004_bib0011","doi-asserted-by":"crossref","first-page":"H1903","DOI":"10.1152\/ajpheart.00980.2020","article-title":"No evidence of racial disparities in blood pressure salt sensitivity when potassium intake exceeds levels recommended in the US dietary guidelines","volume":"320","author":"Kurtz","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.jnma.2022.05.004_bib0012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semnephrol.2013.07.002","article-title":"Racial disparities in kidney disease outcomes","volume":"33","author":"Nicholas","year":"2013","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.jnma.2022.05.004_bib0013","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.ajkd.2019.06.006","article-title":"Genetics and ESKD disparities in African Americans","volume":"74","author":"Umeukeje","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"22","key":"10.1016\/j.jnma.2022.05.004_bib0014","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jnma.2022.05.004_bib0015","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.7326\/M21-0834","article-title":"Management of blood pressure in patients with chronic kidney disease not receiving dialysis: synopsis of the 2021 KDIGO clinical practice guideline","volume":"174","author":"Tomson","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jnma.2022.05.004_bib0016","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/ajh\/hpz090","article-title":"DASH diet and blood pressure among black Americans with and without CKD: the jackson heart study","volume":"32","author":"Tyson","year":"2019","journal-title":"Am J Hypertens"},{"issue":"7","key":"10.1016\/j.jnma.2022.05.004_bib0017","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.clnu.2019.10.004","article-title":"Dietary approaches to stop hypertension and risk of chronic kidney disease: a systematic review and meta-analysis of observational studies","volume":"39","author":"Mozaffari","year":"2020","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.jnma.2022.05.004_bib0018","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.ajkd.2016.05.019","article-title":"DASH (dietary approaches to stop hypertension) diet and risk of subsequent kidney disease","volume":"68","author":"Rebholz","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.jnma.2022.05.004_bib0019","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ckj\/sfw046","article-title":"Short-term effects of the DASH diet in adults with moderate chronic kidney disease: a pilot feeding study","volume":"9","author":"Tyson","year":"2016","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.jnma.2022.05.004_bib0020","first-page":"S3","article-title":"The global burden of diabetes and its complications: an emerging pandemic","volume":"17","author":"van Dieren","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"8","key":"10.1016\/j.jnma.2022.05.004_bib0021","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2215\/CJN.13111215","article-title":"Diabetes, kidney disease, and cardiovascular outcomes in the jackson heart study","volume":"11","author":"Afkarian","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jnma.2022.05.004_bib0022","series-title":"USRDS 2016 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2016"},{"issue":"4s","key":"10.1016\/j.jnma.2022.05.004_bib0023","first-page":"S1","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","year":"2020","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.jnma.2022.05.004_bib0024","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.jnma.2022.05.004_bib0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jfma.2018.02.007","article-title":"Update of pathophysiology and management of diabetic kidney disease","volume":"117","author":"Lin","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.jnma.2022.05.004_bib0026","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.ackd.2021.09.010","article-title":"Novel anti-inflammatory and anti-fibrotic agents for diabetic kidney disease-from bench to bedside","volume":"28","author":"Nicholas","year":"2021","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"10.1016\/j.jnma.2022.05.004_bib0027","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2337\/dc18-2563","article-title":"hs-CRP Is associated with incident diabetic nephropathy: findings from the Jackson heart study","volume":"42","author":"Sinha","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jnma.2022.05.004_bib0028","doi-asserted-by":"crossref","unstructured":"American Diabetes Association; 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u22122021. Diabetes Care 1 January 2021; 44(Supplement_1): S15\u2013S33. doi:10.2337\/dc21-S002.","DOI":"10.2337\/dc21-S002"},{"issue":"4","key":"10.1016\/j.jnma.2022.05.004_bib0029","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2215\/CJN.07580717","article-title":"Black Americans' perspectives of barriers and facilitators of community screening for kidney disease","volume":"13","author":"Umeukeje","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.jnma.2022.05.004_bib0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.jnma.2022.05.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007165","article-title":"Cardiovascular safety, long-term noncardiovascular safety, and efficacy of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systemic review and meta-analysis with trial sequential analysis","volume":"7","author":"Zhang","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.jnma.2022.05.004_bib0032","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2215\/CJN.18641120","article-title":"Transforming the care of patients with diabetic kidney disease","volume":"16","author":"Brosius","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.jnma.2022.05.004_bib0033","article-title":"Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease","volume":"9","author":"Lo","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jnma.2022.05.004_bib0034","doi-asserted-by":"crossref","first-page":"225","DOI":"10.31128\/AJGP-05-20-5432","article-title":"Current evidence and practical guidance for the use of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes","volume":"50","author":"Zala","year":"2021","journal-title":"Aust J Gen Pract"},{"issue":"5","key":"10.1016\/j.jnma.2022.05.004_bib0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00228-020-03051-3","article-title":"Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review","volume":"77","author":"Bamgboye","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jnma.2022.05.004_bib0036","first-page":"1","article-title":"Effects of sodium-glucose cotransporter 2 on amputation events: a systematic review and meta-analysis of randomized-controlled trials","author":"See","year":"2021","journal-title":"Pharmacology"},{"issue":"23","key":"10.1016\/j.jnma.2022.05.004_bib0037","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jnma.2022.05.004_bib0038","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.120.051898","article-title":"Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes","volume":"143","author":"Filippatos","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2022.05.004_bib0039","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/PPA.S106821","article-title":"Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors","volume":"10","author":"Polonsky","year":"2016","journal-title":"Patient Prefer Adher"},{"issue":"2","key":"10.1016\/j.jnma.2022.05.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212117","article-title":"Racial and ethnic disparities in medication adherence among privately insured patients in the United States","volume":"14","author":"Xie","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jnma.2022.05.004_bib0041","first-page":"297","article-title":"Critical race theory as a lens for examining primary care provider responses to persistently-elevated HbA1c","volume":"113","author":"Cunningham","year":"2021","journal-title":"J Natl Med Assoc"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968422000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968422000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:19:03Z","timestamp":1758435543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968422000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0027968422000852"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2022.05.004","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiopathogenesis of kidney disease in minority populations and an updated special focus on treatment in diabetes and hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 National Medical Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}